| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/25/2013 | US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 07/25/2013 | US20130190287 Therapeutically active compounds and their methods of use |
| 07/25/2013 | US20130190286 B-raf kinase inhibitors |
| 07/25/2013 | US20130190273 Methods for Treating Amyotrophic Lateral Sclerosis Using Pro-Neurogenic Compounds |
| 07/25/2013 | US20130190262 Compounds Useful for Inhibiting Chk1 |
| 07/25/2013 | US20130190259 Arthropodicidal anthranilamides |
| 07/25/2013 | US20130190258 Compounds for inhibition of cancer cell proliferation |
| 07/25/2013 | US20130189228 Cyano anthranilamide insecticides |
| 07/25/2013 | CA2861339A1 Metalloenzyme inhibitor compounds |
| 07/24/2013 | EP2617721A2 Novel heterocyclic compound, and composition for treating inflammatory diseases using same |
| 07/24/2013 | EP2617719A1 Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| 07/24/2013 | EP2617717A1 P2x4 receptor antagonist |
| 07/24/2013 | EP2617713A1 New Pharmaceutical Compounds |
| 07/24/2013 | EP2617712A1 Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using same |
| 07/24/2013 | EP2616478A2 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo |
| 07/24/2013 | EP2616460A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine. |
| 07/24/2013 | EP2616459A1 Pyridine compounds for controlling invertebrate pests i |
| 07/24/2013 | EP2616458A1 Pyridine compounds for controlling invertebrate pests ii |
| 07/24/2013 | EP2616457A1 Substituted bipyridines for use in organic light-emitting devices |
| 07/24/2013 | EP2616445A2 Estrogen receptor modulators and uses thereof |
| 07/24/2013 | EP2616442A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 07/24/2013 | EP2616441A2 Pyridine compounds and the uses thereof |
| 07/24/2013 | EP2616437A1 Pesticidal arylpyrrolidines |
| 07/24/2013 | EP2616070A1 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors |
| 07/24/2013 | EP2615916A1 Fused pyrazole derivatives as novel erk inhibitors |
| 07/24/2013 | CN1980899B Quinazolinone derivatives as parp inhibitors |
| 07/24/2013 | CN103221405A Substituted pyridine compound |
| 07/24/2013 | CN103221404A Nitrogen heterocyclic compounds useful as PDE10 inhibitors |
| 07/24/2013 | CN103221403A Heterocyclic compounds and their uses |
| 07/24/2013 | CN103221402A Triazole derivatives and their use for neurological disorders |
| 07/24/2013 | CN103221398A Tetrazine-trans-yclooctene ligation for the rapid construction of radionuclide labeled probes |
| 07/24/2013 | CN103221395A Insecticidal compounds |
| 07/24/2013 | CN103221394A Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide |
| 07/24/2013 | CN103221392A Bridged spiro[2.4]heptane ester derivatives |
| 07/24/2013 | CN103221094A Crystalline form of an inhibitor of MDM2/4 and P53 interaction |
| 07/24/2013 | CN103220910A Methods of use of cyclic amide derivatives to treat schizophrenia |
| 07/24/2013 | CN103214467A 5-[[4-[(2, 3-dimethyl-2H-indazole-6-yl) methylamino]-2-pyrimidyl] amino]-2-methyl-benzsulfamide derivative and preparation method and applications thereof |
| 07/24/2013 | CN103214466A Methyl arylpyrazole fluorouracil compounds, and preparation method and application thereof |
| 07/24/2013 | CN103214464A Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 07/24/2013 | CN103214463A Novel preparation method of sertindole |
| 07/24/2013 | CN103214462A Preparation method of esomeprazole sodium salt |
| 07/24/2013 | CN103214461A Quinoline derivative and application thereof |
| 07/24/2013 | CN103214460A Chemical compounds |
| 07/24/2013 | CN103214459A Pantoprazole sodium crystalline compound, pharmaceutical composition and preparation method thereof |
| 07/24/2013 | CN103214458A Esomeprazole magnesium dihydrate preparation method |
| 07/24/2013 | CN103214457A Azole antifungal compound, its preparation method and application |
| 07/24/2013 | CN103214456A Benzimidazole compound with antitumour activity as well as preparation method and application thereof |
| 07/24/2013 | CN103214455A Method for preparing bilastine |
| 07/24/2013 | CN103214454A Bilastine crystal and preparation method thereof |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN102627631B Benzoheterocycle compound and preparation method as well as medical application thereof |
| 07/24/2013 | CN102336740B Novel imidazole compound and its application |
| 07/24/2013 | CN102249987B Combretastatin compound and preparation method and application thereof |
| 07/24/2013 | CN102112439B 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 07/24/2013 | CN101885722B Heterocycle alkyne and benzene compound, medicinal composition and application thereof |
| 07/24/2013 | CN101817787B Androgen receptor antagonist for resisting prostate cancer |
| 07/24/2013 | CN101600682B Process for making 3-substituted 2-amino-5-halobenzamides |
| 07/24/2013 | CN101560186B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN101405264B Piperidinyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 07/24/2013 | CN101258131B 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 07/24/2013 | CN101128199B Monocyclic heterocycles as kinase inhibitors |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492551 Process for preparing an optically active proton pump inhibitor |
| 07/23/2013 | US8492428 Small-molecule botulinum toxin inhibitors |
| 07/23/2013 | US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/23/2013 | US8492409 1-substituted pyridyl-pyrazolyl amide compounds and uses thereof |
| 07/23/2013 | US8492408 Benzimidazole derivatives and their use for modulating the GABAA receptor complex |
| 07/23/2013 | US8492403 Bicyclic derivatives as modulators of voltage gated ion channels |
| 07/23/2013 | US8492398 Spiroazaindoles |
| 07/23/2013 | US8492388 Fungicide hydroximoyl-tetrazole derivatives |
| 07/23/2013 | US8492387 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/23/2013 | US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists |
| 07/23/2013 | US8492374 Azaazulene compounds |
| 07/23/2013 | US8492111 Arylalkylamine compound and process for preparing the same |
| 07/23/2013 | CA2607106C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 07/23/2013 | CA2599348C Indole compound and use thereof |
| 07/23/2013 | CA2583967C 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/23/2013 | CA2545261C Piperidine-substituted indoles- or heteroderivatives thereof |
| 07/18/2013 | WO2013105676A1 Benzimidazole derivatives as mch receptor antagonists |
| 07/18/2013 | WO2013105608A1 P2x4 receptor antagonist |
| 07/18/2013 | WO2013105118A1 A process for synthesis of syn azido epoxide and its use as intermediate the synthesis of amprenavir & saquinavir |
| 07/18/2013 | WO2013104573A1 Pyridazine amide compounds and their use as syk inhibitors |
| 07/18/2013 | WO2013076315A3 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides |
| 07/18/2013 | WO2013070852A3 Compounds and compositions used to epigenetically transform cells and methods related thereto |
| 07/18/2013 | WO2013048949A3 Selective nr2b antagonists |
| 07/18/2013 | US20130184463 Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 07/18/2013 | US20130184460 Glycine transporter inhibiting substances |
| 07/18/2013 | US20130184313 Nicotinic acetylcholine receptor ligands and the uses thereof |
| 07/18/2013 | US20130184309 Metalloenzyme inhibitor compounds |
| 07/18/2013 | US20130184301 Methods of Treating Post-Traumatic Stress Disorder Using Pro-Neurogenic Compounds |
| 07/18/2013 | US20130184300 Methods of Treating Traumatic Brain Injury Using Pro-Neurogenic Compounds |
| 07/18/2013 | US20130184298 Dihydrobenzoquinazolinone m1 receptor positive allosteric modulators |
| 07/18/2013 | US20130184284 Diaminocyclohexane compounds and uses thereof |
| 07/18/2013 | US20130184277 Adamantyl diamide derivatives and uses of same |
| 07/18/2013 | US20130184271 Methods for Treating Parkinson's Disease Using Pro-Neurogenic Compounds |
| 07/18/2013 | US20130184262 Diaminocyclohexane compounds and uses thereof |
| 07/18/2013 | US20130184261 Pyridazinone derivatives |
| 07/18/2013 | US20130184260 Pyridazinone derivatives |
| 07/18/2013 | US20130184259 Pyridones useful as inhibitors of kinases |
| 07/18/2013 | US20130184258 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |